Skip to main content
QMSQMS
QMS
  • Welcome to your QMS
  • Quality Manual
  • Procedures
  • Records
  • Legit.Health Plus Version 1.1.0.0
  • Legit.Health Plus Version 1.1.0.1
  • Legit.Health version 2.1 (Legacy MDD)
  • Legit.Health Utilities
  • Licenses and accreditations
  • Applicable Standards and Regulations
  • BSI Non-Conformities
    • Technical Review
    • Clinical Review
      • Round 1
        • Item 0: Background & Action Plan
        • Item 1: CER Update Frequency
        • Item 2: Device Description & Claims
        • Item 3: Clinical Data
        • Item 4: Usability
        • Item 5: PMS Plan
        • Item 6: PMCF Plan
        • Item 7: Risk
        • MDCG 2020-13 & CER Template (reference)
          • MDCG 2020-13 (CEAR) sections
          • CER Template sections
            • 00 Front matter, introduction, writing tips
            • 1. Administrative particulars
            • 2. Executive summary
            • 3. Scope of the clinical evaluation
            • 4. Clinical evaluation plan — Summary
            • 5. Common specifications and harmonised standards
            • 6. Clinical background, current knowledge, state of the art
            • 7. Equivalence
            • 8. Clinical evidence review
            • 9. Clinical evidence analysis — GSPRs
            • 10. Clinical evidence analysis — Benefit-risk profile
            • 15. Vendor services annex (non-normative)
            • 11–14. Conclusions, Author CVs, References, Excluded sources
        • Adequacy review
        • Coverage matrix
        • task-3b2-3b3-legacy-rwe-study
        • task-3b4-mrmc-dark-phototypes
  • Pricing
  • Public tenders
  • BSI Non-Conformities
  • Clinical Review
  • Round 1
  • MDCG 2020-13 & CER Template (reference)
  • CER Template sections
  • 7. Equivalence

7. Equivalence

Source: CER Template.pdf page 18 (document: Mantra Systems Free CER Template, Edition 2)

This section is only applicable when equivalence is being claimed.

Equivalence is the process of using clinical data from other devices, claimed to be equivalent to the subject device, to provide evidence of the safety and performance of the subject device.

Equivalence must be demonstrated in three domains:

  1. Clinical characteristics
  2. Technical characteristics
  3. Biological characteristics

7.1 Equivalent device(s)​

Name the equivalent device(s) and give details of the manufacturer(s).

7.2 Statement of equivalence & access to data​

Write a declaration that the base requirements for claiming equivalence under MDR have been met (assuming this is true). A rationale for justifying sufficient access to equivalent device information must be set out. For Class III devices claiming equivalence to another manufacturer's product, a contract must also be in place granting full access to the equivalent device technical files.

7.3 Equivalence rationale -- technical, biological and clinical characteristics​

A comparison of technical, biological and clinical characteristics of the subject and equivalent device should be set out, normally in table form. For each line item, include an assessment of the impact of any differences on safety or performance. Ensure that determinations are evidence-based and justified.

CharacteristicSubject deviceEquivalent deviceDifference and impact on safety/performance
Technical_______________
Biological_______________
Clinical_______________

7.4 Equivalence summary​

Summarise this section with a set of conclusions about equivalence.

Conclude whether equivalence is demonstrated or not. If it is, conclude and confirm that the differences between the devices are not expected to affect the clinical performance and clinical safety of the device under evaluation. Include a description of any limitations and gaps in the equivalence assessment.

Previous
6. Clinical background, current knowledge, state of the art
Next
8. Clinical evidence review
  • 7.1 Equivalent device(s)
  • 7.2 Statement of equivalence & access to data
  • 7.3 Equivalence rationale -- technical, biological and clinical characteristics
  • 7.4 Equivalence summary
All the information contained in this QMS is confidential. The recipient agrees not to transmit or reproduce the information, neither by himself nor by third parties, through whichever means, without obtaining the prior written permission of Legit.Health (AI Labs Group S.L.)